Literature DB >> 20944417

Genistein induced apoptotic cell death in adult T-cell leukemia cells through estrogen receptors.

Masao Yamasaki1, Ayako Mukai, Masayo Ohba, Yoshihiro Mine, Yoichi Sakakibara, Masahito Suiko, Kazuhiro Morishita, Kazuo Nishiyama.   

Abstract

Adult T-cell leukemia (ATL) occurs in human T-lymphotropic virus type I-infected individuals and is endemic to the southwestern area of Kyushu in Japan. Here, we found that nM levels of genistein and 17β-estradiol had cytotoxic effects on ATL cells and activated caspase-3. The estrogen receptor antagonist ICI182780 negated the cytotoxic effect of genistein. In addition, G protein-coupled estrogen receptor agonist G-1 also had a cytotoxic effect on ATL cells. This is the first report suggesting that estrogen receptors are a molecular target for ATL therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944417     DOI: 10.1271/bbb.100359

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  5 in total

Review 1.  Development of subtype-selective oestrogen receptor-based therapeutics.

Authors:  Stefan Nilsson; Konrad F Koehler; Jan-Åke Gustafsson
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

2.  Estrogen action and prostate cancer.

Authors:  Jason L Nelles; Wen-Yang Hu; Gail S Prins
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

3.  Comparison of Cultivars and Seasonal Variation in Blueberry (Vaccinium Species) Leaf Extract on Adult T-Cell Leukemia Cell Line Growth Suppression.

Authors:  Hisahiro Kai; Takuichi Fuse; Hisato Kunitake; Kazuhiro Morishita; Koji Matsuno
Journal:  Medicines (Basel)       Date:  2014-06-30

4.  Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids.

Authors:  Katrin Sak; Hele Everaus
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

5.  Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.

Authors:  Irfana Muqbil; Ashiq Masood; Fazlul H Sarkar; Ramzi M Mohammad; Asfar S Azmi
Journal:  Cancers (Basel)       Date:  2011-01-21       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.